rs7533978
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_024408.4(NOTCH2):c.939C>T(p.Gly313Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00478 in 1,614,062 control chromosomes in the GnomAD database, including 323 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.025 ( 152 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 171 hom. )
Consequence
NOTCH2
NM_024408.4 synonymous
NM_024408.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.193
Publications
2 publications found
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
- acroosteolysis dominant typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- Alagille syndrome due to a NOTCH2 point mutationInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Alagille syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 1-119969680-G-A is Benign according to our data. Variant chr1-119969680-G-A is described in ClinVar as Benign. ClinVar VariationId is 532030.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.193 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.083 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOTCH2 | ENST00000256646.7 | c.939C>T | p.Gly313Gly | synonymous_variant | Exon 6 of 34 | 1 | NM_024408.4 | ENSP00000256646.2 | ||
| NOTCH2 | ENST00000479412.2 | n.1077C>T | non_coding_transcript_exon_variant | Exon 5 of 14 | 1 | |||||
| NOTCH2 | ENST00000640021.1 | n.*63C>T | non_coding_transcript_exon_variant | Exon 3 of 12 | 5 | ENSP00000492223.1 | ||||
| NOTCH2 | ENST00000640021.1 | n.*63C>T | 3_prime_UTR_variant | Exon 3 of 12 | 5 | ENSP00000492223.1 |
Frequencies
GnomAD3 genomes AF: 0.0246 AC: 3745AN: 152126Hom.: 151 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3745
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00635 AC: 1593AN: 250998 AF XY: 0.00435 show subpopulations
GnomAD2 exomes
AF:
AC:
1593
AN:
250998
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00271 AC: 3965AN: 1461818Hom.: 171 Cov.: 33 AF XY: 0.00230 AC XY: 1674AN XY: 727214 show subpopulations
GnomAD4 exome
AF:
AC:
3965
AN:
1461818
Hom.:
Cov.:
33
AF XY:
AC XY:
1674
AN XY:
727214
show subpopulations
African (AFR)
AF:
AC:
3104
AN:
33474
American (AMR)
AF:
AC:
186
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39694
South Asian (SAS)
AF:
AC:
9
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
AC:
23
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
284
AN:
1111966
Other (OTH)
AF:
AC:
359
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
228
457
685
914
1142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0246 AC: 3750AN: 152244Hom.: 152 Cov.: 32 AF XY: 0.0240 AC XY: 1783AN XY: 74444 show subpopulations
GnomAD4 genome
AF:
AC:
3750
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
1783
AN XY:
74444
show subpopulations
African (AFR)
AF:
AC:
3545
AN:
41526
American (AMR)
AF:
AC:
141
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21
AN:
68020
Other (OTH)
AF:
AC:
39
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
170
340
511
681
851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Hajdu-Cheney syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.